Healios K.K.TSE 4593

株式会社ヘリオス · Pharmaceutical · FY ends Dec

Share price at FY-end
—
FY ending Dec 2025
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥41.5M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 鍵本 忠尚 27,830,300 24.05% — —
2 MSIP Client Securities 6,069,463 5.24% — —
3 BNY GCM CLIENT ACCOUNT JPRD AC ISG 4,353,641 3.76% — —
4 GOLDMAN,SACHS & CO.REG 3,564,796 3.08% — —
5 BNYM SA/NV FOR BNYM FOR BNYM GCM CLIENT ACCTS M ILM FE 3,279,802 2.83% — —
6 楽天証券株式会社共有口 2,798,400 2.42% — —
7 BBH FOR FIDELITY FUNDS - PACIFIC POOL 2,177,900 1.88% — —
8 株式会社SBI証券 2,151,024 1.86% — —
9 株式会社RACTHERA 1,500,000 1.30% — —
10 JPモルガン証券株式会社 1,236,387 1.07% — —

Officers' holdings and pay

NameTitleSharesValuePay
鍵本 忠尚 Director 27,830,300 — —
樫井 正剛 Director 200 — —
リチャード・キンケイド Director 187,500 — —
余語 裕子 Director — — —
グレン・ゴームリー Director — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 — ¥-22.58 — — 115,727,200
FY ending Dec 2024 — ¥-30.21 — — 90,219,200
FY ending Dec 2023 — ¥-42.37 — — 74,543,600
FY ending Dec 2022 — ¥-147.59 — — 63,204,200
Source: annual securities reports on EDINET. Values are estimates. Methodology